肝癌的实验室标志物检测现状与展望  

The current status and future prospects of laboratory biomarkers in the diagnosis of liver cancer

作　　者：段秀枝[1] 陶志华[1] 

机构地区：[1]浙江大学医学院附属第二医院检验科,杭州310009

出　　处：《中华检验医学杂志》2014年第2期84-86,共3页Chinese Journal of Laboratory Medicine

基　　金：国家自然科学基金面上项目（81271917）

摘　　要：肝癌在我国一直具有较高的发病率和死亡率。随着新研究技术和实验室检测方法发展，寻找高灵敏度和特异性的肝癌实验室诊断标志物及其检测方法是研究者共同目标。临床实验室只有系统地了解这些实验室标志物及其在肝癌进展中变化规律，并将其运用于肝癌诊断、治疗监测和预后判断，切实提高肝癌的实验室诊断能力，才能更好更有效地服务于临床。r手华裣验医学杂岙，2014，37：觯彤）Liver cancer has a high morbidity and mortality in China. With new technologies and diagnostic instruments being developed, it is a common goal for researchers to discover some new diagnostic biomarkers of high sensitivity and specificity on liver cancer. The clinical laboratory is responsible to choose and understand the diagnosis value of these laboratory indicators and variation in the liver cancer progress. Then, these new biomarkers in screening for early malignancy, aiding cancer diagnosis, determining prognosis can be used effectively in the clinical laboratory to improve laboratory diagnostic capacity in order to serve the clinic more effectively and better. （Chin J Lab Med,2014,37：84-86）

关 键 词：肝肿瘤 实验室技术和方法 生物学标记 

分 类 号：R735.7[医药卫生—肿瘤]